How high-density lipoprotein protects against the effects of lipid peroxidation

被引:157
作者
Mackness, MI [1 ]
Durrington, PN [1 ]
Mackness, B [1 ]
机构
[1] Univ Manchester, Manchester Royal Infirm, Dept Med, Manchester M13 9WL, Lancs, England
关键词
D O I
10.1097/00041433-200008000-00007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The protective effect of HDL against the development of atherosclerosis appears to be multifaceted involving a number of mechanisms. One of the major mechanisms is, however, the ability of HDL to decrease, directly or indirectly, the lipid peroxidation of LDL, The hydrolysis of lipid peroxides by PON1 makes a major contribution to this effect of HDL. Evidence is accumulating that the PON1 activity of human serum can be modulated by a variety of natural compounds and that these may increase or decrease the protective ability of PON1 and therefore of HDL on which it is exclusively located. Modulations of PON1 that enhance its activity may help to delay the atherosclerotic process. Curr Opin Lipidol 11:383-388. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:383 / 388
页数:6
相关论文
共 64 条
  • [21] Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients
    Hasselwander, O
    Savage, DA
    McMaster, D
    Loughrey, CM
    McNamee, PT
    Middleton, D
    Nicholls, DP
    Maxwell, AP
    Young, IS
    [J]. KIDNEY INTERNATIONAL, 1999, 56 (01) : 289 - 298
  • [22] Metabolism of oxidized phosphatidylcholines formed in oxidized low density lipoprotein by lecithin-cholesterol acyltransferase
    Itabe, H
    Hosoya, R
    Karasawa, K
    Jimi, S
    Saku, K
    Takebayashi, S
    Imanaka, T
    Takano, T
    [J]. JOURNAL OF BIOCHEMISTRY, 1999, 126 (01) : 153 - 161
  • [23] Klimov A. N., 1998, ADV LIPOPROTEIN ATHE, P78
  • [24] La Du B.N., 1992, PHARMACOGENETICS DRU, P51
  • [25] All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified -: Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase
    Lee, C
    Sigari, F
    Segrado, T
    Hörkkö, S
    Hama, S
    Subbaiah, P
    Miwa, M
    Navab, M
    Witztum, JL
    Reaven, PD
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (06) : 1437 - 1446
  • [26] Mackness B, 2000, EUR J CLIN INVEST, V30, P4
  • [27] Polymorphisms of paraoxonase genes and low-density lipoprotein lipid peroxidation
    Mackness, B
    Durrington, PN
    Mackness, MI
    [J]. LANCET, 1999, 353 (9151) : 468 - 469
  • [28] Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification
    Mackness, B
    Mackness, MI
    Arrol, S
    Turkie, W
    Durrington, PN
    [J]. FEBS LETTERS, 1998, 423 (01) : 57 - 60
  • [29] Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon
    Mackness, B
    Mackness, MI
    Arrol, S
    Turkie, W
    Durrington, PN
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 (02) : 265 - 268
  • [30] Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy
    Mackness, B
    Durrington, PN
    Abuashia, B
    Boulton, AJM
    Mackness, MI
    [J]. CLINICAL SCIENCE, 2000, 98 (03) : 355 - 363